Ophthalmology is a surgical subspecialty within medicine that deals with the diagnosis and treatment of eye disorders.
New York Eye and Ear Infirmary of Mount Sinai (NYEE) is located at East 14th Street and Second Avenue in lower Manhattan, New York City. Founded on August 14, 1820, NYEE is America's first specialty hospital and one of the most prominent in the fields of ophthalmology and otolaryngology in the world, providing primary inpatient and outpatient care in those specialties. Previously affiliated with New York Medical College, as of 2013 it is affiliated with the Icahn School of Medicine at Mount Sinai as a part of the membership in the Mount Sinai Health System.
The Illinois Eye & Ear Infirmary (IEEI) is a center of ophthalmology and otolaryngology research and clinical practice.
The Blind Leading the Blind, Blind, or The Parable of the Blind is a painting by the Netherlandish Renaissance artist Pieter Bruegel the Elder, completed in 1568. Executed in distemper on linen canvas, it measures 86 cm × 154 cm. It depicts the Biblical parable of the blind leading the blind from the Gospel of Matthew 15:14, and is in the collection of the Museo di Capodimonte in Naples, Italy.
The John A. Moran Eye Center at the University of Utah is an ophthalmology clinical care and research facility in the Mountain West. Physicians provide comprehensive care in all ophthalmic subspecialties. Moran supports 15 research laboratories to develop sight-saving treatments.
Master of Medicine (MMed) is a postgraduate professional clinical degree awarded by medical schools to physicians following a period of instruction, supervised clinical rotations, and examination. The degree usually takes three years to complete, but may take up to four years in some countries. It is awarded by both surgical and medical subspecialties and usually includes a dissertation component. The degree may complement an existing fellowship in the chosen specialty or be the sole qualification necessary for registration as a specialist.
Paul T. Finger, MD, FACS, is an ophthalmologist in New York, New York, specializing in ocular oncology. Finger is a Clinical Professor of Ophthalmology at the New York University School of Medicine in New York City, New York. He is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital and NYU School of Medicine. He is Chair of the Ophthalmic Oncology Task Force for the American Joint Committee on Cancer (AJCC), wrote the eye cancer staging systems section for the Union International for Cancer Control (UICC). As Chair, he brought together an OOTF to develop consensus eye plaque radiation guidelines for The American Brachytherapy Society - American Association of Physicists in Medicine. Dr. Finger was the first the only ophthalmologist asked to serve on the 2012 American Association of Physicists in Medicine’s Task Group-129 that produced both dosimetry and quality assurance standards for plaque brachytherapy. As of 2021, Dr. Finger has authored over 335 peer-review scientific articles, 2 books, 54 book chapters and 2 web sites.
Jerry A. Shields is an ophthalmologist practicing at the Wills Eye Institute in Philadelphia, Pennsylvania, specializing in ocular oncology. He is also a professor at Thomas Jefferson University.
Geoffrey Rose BSc MBBS MS DSc MRCP FRCS FRCOphth is an English ophthalmologist and Past-President of both the British OculoPlastic Surgery Society (BOPSS) and the European Society of Ophthalmic Plastic and Reconstructive Surgeons (ESOPRS).
Gholam A. Peyman is an ophthalmologist, retina surgeon, and inventor. He is best known for his invention of LASIK eye surgery, a vision correction procedure designed to allow people to see clearly without glasses. He was awarded the first US patent for the procedure in 1989.
Bascom Palmer Eye Institute is the University of Miami School of Medicine's ophthalmic care, research, and education center. The institute is based in the Health District of Miami, Florida, and has been ranked consistently as the best eye hospital and vision research center in the nation.
The Filatov Institute is a research institute and a large ophthalmology (eye) hospital in Odesa, Ukraine. It was founded by Vladimir Filatov, an academic ophthalmologist. Its mission is the study of eye diseases and injuries, the training of ophthalmologists and the provision of eye care in Ukraine. The institute has 700 staff including 27 professors.
David J. Apple was an ophthalmic pathologist who conducted research on the pathology of intraocular lens complications as well as ophthalmic surgery in general. He was a medical historian and biographer of Sir Harold Ridley, the inventor of the intraocular lens (IOL).
He often stated that Harold Ridley changed the world. What we can say about David Apple is that he vastly improved the world that Harold Ridley changed
Yog Raj Sharma is an Indian ophthalmologist and ex-chief of Dr. Rajendra Prasad Centre for Ophthalmic Sciences of the All India Institute of Medical Sciences (AIIMS), New Delhi, the apex body of the National Programme for the Control of Blindness, a Government of India initiative to reduce the prevalence of blindness in India. He is the Chairman of the Task Force on Prevention and Control of Diabetic Retinopathy Group and the Co-Chairman of the National Task Force on Prevention of Blindness from Retinopathy of Prematurity under the Ministry of Health and Family Welfare of the Government of India. An advisor to the Ministry of Health and Family Welfare, India. Sharma was honored by the Government of India in 2015 with Padma Shri, the fourth highest Indian civilian award. In 2005, Yog Raj Sharma's published article on "Pars plana vitrectomy vs scleral buckling in rhegmatogenous retinal detachment" in Acta Ophthalmologica Scandinavica and in November 2021, American society of retina specialists cited it as top 100 publications on retinal detachment management in the last ~121 years. Of these top hundred publications, only nineteen countries contributed, three of the contributing countries were Asian and from India this study was the sole contribution. Dr Sharma called it 'the singular biggest achievement of his career" in an article published in Daily Excelsior, Jammu in December 2021.
J. William Harbour, M.D., is an American ophthalmologist, ocular oncologist and cancer researcher. He is currently Chair of the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas. He previously served as the vice chair and director of ocular oncology at the Bascom Palmer Eye Institute and associate director for basic science at the Sylvester Comprehensive Cancer Center of the University of Miami's Miller School of Medicine.
Lorenz Eugene Zimmerman was an American ophthalmologist and an ophthalmic pathologist.
C. Stephen Foster is an American ophthalmologist, known for his research and treatment of ocular inflammatory disease (OID) with immunomodulatory therapy. He has published over 700 peer reviewed journal articles and authored 3 textbooks in his field.
Daniel M. Albert is an American ophthalmologist, ocular cancer researcher, medical historian, and collector of rare books and ocular equipment. As of 2018, he is Professor of Ophthalmology at the Casey Eye Institute, Oregon Health & Science University.
Atul Kumar is an Indian ophthalmologist who is currently the Chief & Professor of Ophthalmology at Dr. Rajendra Prasad Centre for Ophthalmic Sciences (RPC-AIIMS), the national apex ophthalmic centre at All India Institute of Medical Sciences, Delhi. He was awarded the Padma Shri award in January 2007 for his services to the medical field. He specializes in vitreoretinal surgery and also heads the Vitreo-Retinal, Uvea and ROP services at RPC-AIIMS.
Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.
